SAVA Q3 2021 Earnings — Cassava Sciences, Inc. Revenue & Financial Results | Market Cap Arena

SAVACassava Sciences, Inc.

$115M

Q3 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$8M

Operating Income

-$10M

Net Income

-$10M

EPS (Diluted)

$-0.24

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$15M

Free Cash Flow

-$37M

Stock-Based Comp.

$572,000

Balance Sheet

Total Assets

$274M

Total Liabilities

$7M

Stockholders' Equity

$268M

Cash & Equivalents

$242M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$8M	-$399,000	-1915.3%
Operating Income	-$10M	-$1M	-578.7%
Net Income	-$10M	-$1M	-568.7%